In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bigfoot Biomedical, Inc.

https://www.bigfootbiomedical.com/

Latest From Bigfoot Biomedical, Inc.

Tech Transfer Roundup: MD Anderson Working To Unlock Promise Of Tumor-Infiltrating Lymphocytes

The center is partnering with Obsidian to make autologous TILs work better after being infused back into patients by using IL-15, which may be less toxic than the high-dose IL-2 currently used.

Deals Business Strategies

Medtronic Adds Smart Insulin Pen By Acquiring Companion Medical

The deal is part of Medtronic's ongoing strategy to revive its diabetes business with technology that simplifies insulin delivery. 

Commercial M & A

ADA 2020: CGM Maker Dexcom Gains CE Mark, Launches G6 Pro While Rivalry With Abbott Builds

Dexcom’s CEO explained the company’s strategy for continued growth, including marketing opportunities for its G6 and G6 Pro continuous glucose monitors and plans for the next-gen G7 CGM.

Diabetic Care Digital Health

Bigfoot Biomedical Closes $55M Series C Financing, Plans FDA Filing For Diabetes System

Diabetes-care company Bigfoot Biomedical announced it raised $55m in a Series C round to support US FDA submission for its insulin delivery system.

Financing Diabetic Care
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Monitoring Equipment & Devices
  • Other Names / Subsidiaries
    • Asante Solutions, Inc.
    • Patients Pending Ltd
    • Timesulin
UsernamePublicRestriction

Register